By Michele Maatouk
Date: Tuesday 31 Mar 2026
(Sharecast News) - Shares in Apellis Pharmaceuticals rocketed on Tuesday after it agreed to be bought by Biogen in a $5.6bn deal.
By Abigail Townsend
Date: Wednesday 20 Oct 2021
(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.
By Abigail Townsend
Date: Tuesday 08 Jun 2021
(Sharecast News) - Shares in Biogen closed nearly 40% higher after the biotech's breakthrough Alzheimer's drug received regulatory approval in the US.
| Currency | US Dollars |
| Share Price | $ 209.83 |
| Change Today | $ -0.82 |
| % Change | -0.39 % |
| 52 Week High | $216.28 |
| 52 Week Low | $132.22 |
| Volume | 554,816 |
| Shares Issued | 146.80m |
| Market Cap | $30,803m |
| RiskGrade | 259 |
| Time | Volume / Share Price |
| 16:00 | 128,233 @ $209.83 |
| 15:59 | 100 @ $209.79 |
| 15:59 | 100 @ $209.78 |
| 15:59 | 100 @ $209.75 |
| 15:59 | 200 @ $209.75 |
You are here: research